Immunome, Inc.IMNMNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
-23.23%
↓ 216% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthRecovering
Average
-7.34%
Historical baseline
PeriodValue
2025-23.23%
2024-35.50%
20230.00%
20220.00%
20210.00%
20200.00%
20190.00%
20180.00%